About University of California San Diego ( Site 1002)
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Acceleron Pharma Inc. (a wholly owned subsidiary of Merck Sharp and Dohme, a subsidiary of Merck & Co., Inc.)
2
Clinical Trials at University of California San Diego ( Site 1002)
During the past decade, University of California San Diego ( Site 1002) conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Long-term Follow-up Study of Sotatercept for PAH Treatment (MK-7962-004)
2021-05-12
2027-11-30
Recruiting
700
Study of Sotatercept in Newly Diagnosed Intermediate- and High-Risk PAH Participants (MK-7962-005/A011-13)
2022-03-18
2028-08-31
Recruiting
662
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at University of California San Diego ( Site 1002)
According to Clinical.Site data, the most researched conditions in "University of California San Diego ( Site 1002)" are
"Pulmonary Arterial Hypertension" (2 trials) and "PAH" (1 trials). Many other conditions were trialed in "University of California San Diego ( Site 1002)" in a lesser frequency.
Clinical Trials Intervention Types at University of California San Diego ( Site 1002)
Most popular intervention types in "University of California San Diego ( Site 1002)" are "Biological" (1 trials), "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Sotatercept" (2 trials) and "Placebo" (1 trials). Other intervention names were less common.
Clinical Trials Genders at University of California San Diego ( Site 1002)
The vast majority of trials in "University of California San Diego ( Site 1002)" are
2 trials for "All" genders.
Clinical Trials Status at University of California San Diego ( Site 1002)
Currently, there are NaN active trials in "University of California San Diego ( Site 1002)".
undefined are not yet recruiting,
2 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in University of California San Diego ( Site 1002),
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in University of California San Diego ( Site 1002), 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".